$APRE Announces Certification to Provide Medication Therapy Management in the Home

FAIRFIELD, N.J., April 23, 2012 /PRNewswire/ -- Aperture Health, Inc. (OTC APRE) announced that that James Hennig, R.Ph., CEO of both Aperture Health, Inc. and Triad Therapeutics, Inc., has become certified to provide "MTM Services", commonly known as "Medication Therapy Management" to its patients.  The Company intends to provide MTM Services to patients in the home for their comfort and convenience rather than render the lengthy medication review on site where the patient must come to our facilities. Mr. Hennig will have the ability to bill for the service under Medicare and Medicaid with private insurance providing coverage as we further enhance this service.

James Hennig, R.Ph, Chief Executive Officer and Chairman of the Board of Directors commented, "We are very pleased with obtaining certification to provide MTM Services and further enhance patient medication compliance at home with the intent to decrease re-hospitalizations due to medication errors while providing medical therapies at home."

About Aperture Health, and Triad Therapeutics

Aperture Health through its wholly owned subsidiary Triad Therapeutics operates a fully JCAHO accredited home IV therapy company, achieving this "gold standard" status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Triad's full time marketing and sales personnel continuously represent the company in the core services areas, growing and maintaining the company's referral source base. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.

http://finance.yahoo.com/news/aperture-health...00328.html